HYBRID POLYPEPTIDES ACTING AS DUAL GHSR AND NPY5R AGONISTS

Patent Number: WO-2024003381-A1

Publication Year: 2024

Application Year: 2023

Priority Year: 2022

Jurisdictions: WO

Status: N/A

Inventors:

FOSGERAU KELD PEDERSEN SØREN LJUNGBERG

Applicants:

  1. PEPHEXIA THERAPEUTICS APS

Abstract

The present invention relates to hybrid polypeptides acting as dual GHSR and NPY5R agonists and their use in the treatment of cachexia or anorexia.

Patent Family Records (1)

HYBRID POLYPEPTIDES ACTING AS DUAL GHSR AND NPY5R AGONISTS

PEPHEXIA THERAPEUTICS APS FOSGERAU KELD, PEDERSEN SØREN LJUNGBERG

2024, WO-2024003381-A1

Data Provider: Digital Science